InvestorsHub Logo
Followers 155
Posts 2649
Boards Moderated 0
Alias Born 01/29/2004

Re: frrol post# 353192

Friday, 03/04/2022 2:14:39 PM

Friday, March 04, 2022 2:14:39 PM

Post# of 462979
But, for Anavex, when will it change?

No. Medicine is in constant change, and it's always advancing.


Sure it is --- but ever so slowly and reluctantly. Took over half a century for the germ theory to be accepted and applied. Today, eliminating beta-amyloids and tau clusters have been the "rapidly advancing" putative mechanisms for Alzheimer's treatments now for how many years? How many billions of dollars in how many clinical trials of new, advanced therapeutic agents have repeatedly failed? Has Aduhelm validated this "constant change?"

Of course, beta-amyloids and tau clusters have been the accepted, understood causes of Alzheimer's for several decades. All of this was taught in med-school pathology classes; it's therefore an unbending truth.

If medicine is in "constant change," please tell, then, why Anavex science has taken so long to gain any acceptance in the medical community. Is it because it's flawed, really can't or won't work? Or, on the basis of "standard practice" has medicine simply rejected Anavex because it's new, theoretically implausible, and the described new mechanisms of actions of the Anavex molecules can't, in fact, operate?

If Anavex science is authentic, and medicine is in constant (progressing) change, just when will Anavex gain acceptance? For a number of years, on the basis of positive clinical outcomes, I've projected 2023 to be the "Anavex Year."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News